HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
Moyle
Graeme
G
Chelsea and Westminster Hospital, London, United Kingdom.
Carr
Andrew
A
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000633:toxicity; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D008659:Metabolic Diseases / Q000139:chemically induced*; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000633:toxicity
D019380:Anti-HIV Agents; D011480:Protease Inhibitors